Jove
Visualize
联系我们

相关概念视频

The Ras Gene02:38

The Ras Gene

6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Cell Signaling Feedback Loops01:07

Cell Signaling Feedback Loops

6.6K
Positive and negative feedback loops are crucial for regulating biological signaling systems. These feedback loops are processes that connect output signals to their inputs.
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
6.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.9K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策
  1. 首页
  2. 在stat1和yap1之间进行送循环刺激脂质生物合成,加速瘤生长,并促进突变kras结直肠癌的化疗耐药性.
  1. 首页
  2. 在stat1和yap1之间进行送循环刺激脂质生物合成,加速瘤生长,并促进突变kras结直肠癌的化疗耐药性.

相关实验视频

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.0K

在STAT1和YAP1之间进行送循环刺激脂质生物合成,加速瘤生长,并促进突变KRAS结直肠癌的化疗耐药性.

Shuo Wang1, Shiqi Diao2,3, Hyungdong Kim2,3

  • 1Lady Davis Institute for Medical Research, McGill University, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, QC, Canada. shuo.wang@ladydavis.ca.

Communications biology
|August 25, 2025

在PubMed 上查看摘要

概括
此摘要是机器生成的。

在KRAS突变癌症中,STAT1通过增加脂质的产生,促进结直肠瘤的生长和存活. 针对STAT1-YAP1通路提供了针对耐治疗KRAS突变结肠癌的新策略.

更多相关视频

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.0K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.1K

相关实验视频

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.0K
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.0K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.1K

科学领域:

  • 癌症学
  • 分子生物学
  • 癌症研究

背景情况:

  • 信号转换器和转录1激活器 (STAT1) 传统上具有抗瘤作用.
  • 在瘤状况下,STAT1可以通过不清楚的机制表现出支持生存的功能.
  • 突变KRAS是许多结直肠癌的关键驱动因素,通常与预后不佳有关.

研究的目的:

  • 研究STAT1在具有野生型或突变KRAS的结直肠瘤细胞中的特定作用.
  • 在突变KRAS的背景下阐明STAT1促进瘤存活和扩散的分子机制.
  • 确定突变KRAS结肠直肠癌的潜在治疗点.

主要方法:

  • 使用具有野生型或突变KRAS的同源性结直肠瘤细胞系.
  • 进行基因表达分析以识别STAT1调节的基因.
  • 研究了STAT1酸化在S727中的作用及其对脂质生物合成途径的影响.
  • 分析了STAT1-YAP1-TEAD4轴及其对治疗耐药性的贡献.

主要成果:

  • 在突变的KRAS结直肠瘤细胞中,STAT1特别促进生存和增殖.
  • 在依赖于STAT1 S727酸化的方式上调醇和脂质生物合成基因,包括SREBP1和SREBP2.
  • 一个涉及STAT1,YAP1和TEAD4的正反循环放大了突变KRAS细胞的脂质产生和瘤生长.
  • 在突变的KRAS结肠癌中,STAT1- YAP1轴对美酸途径抑制剂和EGFR向治疗具有耐药性.
  • 结论:

    • 通过促进脂质生物合成,STAT1在突变的KRAS结直肠癌中起着关键的生存作用.
    • 在这种情况下,STAT1- YAP1通路是治疗耐药性的关键媒介.
    • 针对STAT1- YAP1相互作用为突变KRAS结肠直肠癌提供了一个有希望的治疗策略.